Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

Researchers have said that vitamin D could be the vital ‘missing link’ in managing type 2 diabetes. A new study has found ...

These drugs may affect blood pressure by inhibiting prostaglandin synthesis, which may affect arteriolar smooth muscle tone and natriuresis. Since many patients with conditions such as ...

Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and 10 deaths ...

Diet plays a crucial role in health outcomes within the Black community, where certain conditions occur at higher rates due ...

Get detailed information on Semaglutide, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

Viatris is poised for appreciation with new product launches and a stronger balance sheet. Read why VTRS stock is a buy due ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

such as new drug and material synthesis, possible.” The merger comes at a time when the pharma industry is increasingly embracing digital technologies like AI and quantum computing in a bid to ...

The companies’ CAR-T seemed to cause fewer movement disorders in a multiple myeloma trial than J&J's Carvykti has in other tests, although Wall Street analysts were divided on how the two drugs ...